Catalyst Pharmaceutical CPRX Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Catalyst Pharmaceutical's intangible amortization?
- Catalyst Pharmaceutical (CPRX) reported intangible amortization of $9.7M in Q1 2026.
- How has Catalyst Pharmaceutical's intangible amortization changed year-over-year?
- Catalyst Pharmaceutical's intangible amortization increased by 3.8% year-over-year, from $9.35M to $9.7M.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.